Reduced expression of ppGalNAc-T4 promotes proliferation of human breast cancer cells.

Wu, Qiong; Xie, Xueqin; Zhang, Keren; Niang, Bachir; Liu, Yimin; Zhang, Cheng; Huang, Tianmiao; Huang, Huang; Li, Wenli; Zhang, Jianing; Liu, Yubo

Breast cancer, one of the most frequently diagnosed and aggressive malignancies, is the major cause of cancer-related death greatly threatening women health. Polypeptide N-acetylgalactosaminyltransferase 4 (ppGalNAc-T4), responsible for the initial step of mucin-type O-glycosylation, has been reported to be implicated in diverse types of human tumors. However, the biological role of ppGalNAc-T4 in breast cancer is still undetermined. In this study, we investigate the effects and mechanism of ppGalNAc-T4 to the breast cancer cell proliferation. From analysis of high throughput RNA sequencing datasets of GEO and ArrayExpress, a positive correlation between ppGalNAc-T4 and the recurrence-free survival was observed in multigroup of human breast cancer datasets. Moreover, transcriptomes analysis using RNA-sequencing in MCF7 cells revealed that cell cycle-related genes induced the effects of ppGalNAc-T4 on breast cancer cell proliferation. Additionally, investigations showed that ppGalNAc-T4 impaired cell proliferation in MCF-7 and MDA-MB-231 breast cells. Furthermore, our results suggested that ppGalNAc-T4 knockout activated Notch signaling pathway and enhanced cell proliferation. Collectively, our data indicated that ppGalNAc-T4 affected proliferation of human breast cancer cells, which appears to be a novel target for understanding the underlying molecular mechanism of breast cancer. This article is protected by copyright. All rights reserved.